Who is sponsoring NCT06186713?

NCT06186713 is sponsored by First Affiliated Hospital Xi'an Jiaotong University.

What drugs are being tested in NCT06186713?

Interventions in NCT06186713: This was an observational study, and no Intervention was given to the patients..

What condition does NCT06186713 study?

NCT06186713 studies Acute Myocardial Infarction, Pulmonary Hypertension.

Is NCT06186713 still recruiting?

NCT06186713 is currently completed. Last updated 2 January 2024.

Last reviewed 2024-01-02 · How we verify

NCT06186713: STIMULATE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular Function

Completed Last updated 2 January 2024

What this trial tests

trial testing This was an observational study, and no Intervention was given to the patients. in Acute Myocardial Infarction in 4,784 participants. Completed in 1 August 2023.

Timeline

30 March 2023

Primary endpoint
31 July 2023

1 August 2023

Quick facts

Lead sponsor	First Affiliated Hospital Xi'an Jiaotong University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	4,784
Start date	30 March 2023
Primary completion	31 July 2023
Estimated completion	1 August 2023
Sites	1 location across China

Drugs / interventions tested

This was an observational study, and no Intervention was given to the patients.

Conditions studied

Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →
Pulmonary Hypertension — all drugs for Pulmonary Hypertension →

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Eligibility, any sex, with Acute Myocardial Infarction or Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulmonary hypertension (PH) has a negative effect on acute myocardial infarction (AMI) patients and appears to be closely associated with reduced left ventricular function. However, its impact on AMI patients with reduced left ventricular function remains unclear. This retrospective study included AMI patients with reduced left ventricular function to investigate the prognostic value of PH in this specific type of patient. Meanwhile, a nomogram would be established basing on the identified independent risk factors, hoping to provide a novel risk stratification for them.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prognostic value of pulmonary hypertension with a nomogram in acute myocardial infarction patients with reduced left ventricular function.
Liu Q, Zhao C, Dang P, Li Y, et al · · 2024 · cited 1× · PMID 38711791 · DOI 10.3389/fcvm.2024.1368139

Verify or expand the search:

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06186713 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
Last refreshed: 2 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06186713.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing